Multiple Sclerosis Global Support Network News

"Your trusted source for the latest in MS news and information."

  • MS Info Hub
  • MS News

CMSC 2016 Coverage – MS and Yoga: Author and Instructor...

Mindy Eisenberg is the author of the book “Adaptive Yoga Moves Any Body” and Multiple Sclerosis News Today had the chance to hear exclusively and...

CMSC 2016 Coverage – Patricia Coyle from Stony Brook University: Moving...

As the treatment of relapsing remitting multiple sclerosis continues to add new treatment methods patients with progressive forms of the condition are still waiting...

CMSC 2016 Coverage – Cheri Roseberry from the University of Arizona...

Acknowledging that uncertainty is a key factor in the care and treatment of multiple sclerosis is part of a solution to a problem, finding...

CMSC 2016 Coverage – MS Patients, Physical Therapists Have Distinct...

Understanding and combining decision-making processes of both patients with multiple sclerosis (MS) and physical therapists to improve balance and gait — the movement of...

CMSC 2016 Coverage – Genentech’s Ocrelizumab (Ocrevus) a Promising Therapy...

Genentech, a member of the Roche Group, was founded more than 35 years ago and has been focused on a variety of research fields, including cancer, immunology,...

CMSC 2016 Coverage – Patients With MS Want More Info on...

Individuals with multiple sclerosis (MS) want to hear more from their physicians about wellness issues, such as diet, exercise, stress, and the effects of...

CMSC 2016 Coverage – RRMS Patients’ Five-Year Clinical Outcome Improved...

Results from a Phase 2 clinical trial showed that five-year clinical outcomes of patients with highly active relapsing-remitting multiple sclerosis (RRMS) are significantly improved when...

CMSC 2016 Coverage – STRIVE Study Confirms Tysabri (Natalizumab) Safety...

Results from the STRIVE study support the safety of natalizumab (Tysabri) as a therapy for multiple sclerosis (MS) patients. The study, “Natalizumab in Anti-JC Virus...

CMSC 2016 Coverage – Delayed-release Dimethyl Fumarate (Tecfidera) Benefits Newly...

Newly diagnosed patients with relapsing-remitting multiple sclerosis (RRMS) show significant improvements when treated with delayed-release dimethyl fumarate (DMF), especially in terms of reduction in confirmed disability...

CMSC 2016 Coverage – Cheri Roseberry from the University of Arizona...

From the time a patient is diagnosed with multiple sclerosis there are often more questions than answers for extended periods of time. What that...

Subscribe To Our Newsletter